Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications

I Kanzler, EA Liehn, RR Koenen… - Current pharmaceutical …, 2012 - ingentaconnect.com
Cardiovascular diseases, including atherosclerosis and the dreaded complication
myocardial infarction, represent the major cause of death in western countries. It is now …

Chemokines: established and novel targets in atherosclerosis

RR Koenen, C Weber - EMBO Molecular Medicine, 2011 - embopress.org
In their role as small chemotactic cytokines, chemokines are crucial mediators and
regulators of leukocyte trafficking during immune surveillance and inflammation. Their …

Chemokines in cardiovascular remodeling: clinical and therapeutic implications

G Filippatos, JT Parissis… - Current Molecular …, 2003 - ingentaconnect.com
Chemokines are newly discovered molecules that mediate the migration of leukocytes into
inflammed tissues and control the inflammatory reactions in various immune-mediated …

Anti-inflammatory drugs as promising cardiovascular treatments

F Huet, M Akodad, J Fauconnier… - Expert review of …, 2017 - Taylor & Francis
Introduction: Inflammation is a well-known powerful effector of atherosclerosis development.
Cell infiltration induces inflammatory signal increasing plaque formation as well as its …

The specific role of chemokines in atherosclerosis

V Braunersreuther, F Mach… - Thrombosis and …, 2007 - thieme-connect.com
Atherosclerosis is a chronic inflammatory disease that represents the primary cause of heart
disease and stroke. The recruitment of inflammatory cells in the intima is an essential step in …

Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions?

AJ Lorenzatti, BM Retzlaff - International Journal of Cardiology, 2016 - Elsevier
Atherosclerotic cardiovascular disease is the leading cause of death worldwide. Despite
extraordinary advances in the understanding of the pathophysiology and the utilization of …

Chemokines as effector and target molecules in vascular biology

S Sozzani, A Del Prete, R Bonecchi… - Cardiovascular …, 2015 - academic.oup.com
Chemokines are key mediators of inflammation. In pathological tissues, the main roles of
chemokines are to regulate leucocyte accumulation through the activation of oriented cell …

Chemokines: inflammatory mediators of atherosclerosis

EA Liehn, A Zernecke, O Postea… - Archives of physiology …, 2006 - Taylor & Francis
Atherosclerosis as the underlying mechanisms of myocardial infarction, stroke and
peripheral artery disease remains the major cause of morbidity and mortality in developed …

[HTML][HTML] Targeting the chemokine network in atherosclerosis

Y Yan, M Thakur, EPC van der Vorst, C Weber… - Atherosclerosis, 2021 - Elsevier
Chemokines and their receptors represent a potential target for immunotherapy in chronic
inflammation. They comprise a large family of cytokines with chemotactic activity, and their …

Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias

S Apostolakis, V Amanatidou… - Acta Pharmacologica …, 2010 - nature.com
Current perspectives on the pathogenesis of atherosclerosis strongly support the
involvement of inflammatory mediators in the establishment and progression of …